Goosehead Insurance, Inc.

There were noadoptions, modifications, orterminations by any of our directors or officers of any contract, instruction or written plan for the purchase or sale of securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any non-Rule 10b5-1 trading arrangements requiring disclosure pursuant to Item 408(a) during the fourth quarter of fiscal 2025, except as follows:

On November 5, 2025, Mark K. Miller, the President and Chief Executive Officer of the Company, terminated a Rule 10b5-1 trading arrangement he had previously adopted with respect to the sale of securities of the Company's common stock (the "10b5-1 Plan"). The 10b5-1 Plan was adopted on April 29, 2025, had a term expiring May 1, 2026, and provided for the potential sale of up to 60,000 shares of Company common stock issuable upon the exercise of options. As of the date of termination of his 10b5-1 Plan, Mr. Miller had not sold any shares of common stock under its terms.